Target intelligence / Profile preview

T cell receptor beta variable 5-8 (TRBV5-8)

Target
TRBV5-8
Molecular classification
Receptor, Immunoglobulin superfamily, Variable region of T cell receptor beta chain
01

Overview

T cell receptor beta variable 5-8 (TRBV5-8) is a protein-coding gene segment encoding the variable domain of the beta chain of the T cell receptor (TCR) complex. The TRBV5-8 segment contributes to the antigen recognition site in the TCR, which allows T cells to specifically recognize peptides bound to major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells. The TCR complex is essential for T cell development, immune surveillance, and response against pathogens and tumor cells. Diversity in the TCR beta chain, generated by V(D)J recombination, underpins the adaptive immune repertoire's breadth. Manipulation of individual Vβ domains, such as TRBV5-8, is relevant for next-generation engineered T cell therapies and basic immunology research.

Other names
TRBV5-8TVB58ENSG00000282054
02

Mechanism of action

T cell activation and cytotoxicity: Drugs or cell therapies using or targeting TCR beta variable domains (including TRBV5-8) confer antigen specificity, allowing recognition and killing of target cells (e.g., cancer cells) presenting a specific peptide-MHC ligand. Immunotherapy: Engineered T cells (TCR-T, CAR-T) containing the TRBV5-8 domain can be generated for research or therapy to recognize specific antigens.

03

Biological functions

Antigen recognitionSignal transductionT cell-mediated adaptive immunityDiversity generation via V(D)J recombination
04

Disease associations

CancerInfectionAutoimmune diseaseOther (general immune dysregulation, immunodeficiency)
05

Safety considerations

On-target, off-tumor toxicity and autoimmunity: Engineered T cells or antibodies targeting specific TCR Vβ domains might recognize similar endogenous peptides, leading to cytotoxicity against non-malignant tissuesCytokine release syndrome (CRS): As with other TCR/CAR-based therapies, overstimulation of T cells can drive systemic inflammatory responses.Immunogenicity: Artificial manipulation of TCR sequences may create neo-epitopes recognized as foreign by the host immune system.
06

Interacting drugs

No known approved small-molecule drugs that directly bind to TRBV5-8; however, engineered biologics (e.g., TCR-mimetic antibodies, adoptive T cell therapies) specifically designed to target or utilize certain TRBV segments in clinical and preclinical studies exist

1 more in the full profile.

07

Biomarkers

TCR repertoire analysis: Usage or over-representation of TRBV5-8 can be used as a biomarker for T cell clonality in infection, autoimmunity, or cancerMinimal residual disease monitoringPredictive biomarker: specific Vβ gene usage may predict response or resistance to certain immunotherapies or infections

Beyond the preview

Go deeper on T cell receptor beta variable 5-8 (TRBV5-8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 5-8 (TRBV5-8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call